ArticleCureus2025
Metachronous Bilateral Adrenal Metastasis From Renal Cell Carcinoma Following Robot-Assisted Partial Nephrectomy: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Renal cell carcinoma (RCC) can recur or metastasize years after nephrectomy. While it is uncommon for RCC to metastasize to the adrenal glands, bilateral involvement is very rare and often indicates a more aggressive form of the disease with a poorer prognosis. Therefore, long-term surveillance following nephrectomy is crucial and may improve patients' outcomes. Here, we present a case of a 63-year-old Caucasian male with a past medical history of hypertension, who underwent a robot-assisted right partial nephrectomy and was subsequently lost to follow-up. The pathology report revealed an unclassified renal cell carcinoma, stage 1 (PT1aN0M0). Post-operative imaging two months later showed no evidence of recurrence or metastasis. Despite initial successful management of the primary tumor, three years post-nephrectomy, the patient developed metastatic bilateral adrenal masses, distant metastasis, and rapid disease progression. We report this case to highlight the late metastatic potential of RCC, the rarity of bilateral adrenal involvement, and its associated poor prognosis, while underscoring the importance of post-surgical surveillance following resection.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.